4.7 Article

Extracellular signal-regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin-induced autophagy in human hepatocellular carcinoma

期刊

EUROPEAN JOURNAL OF PHARMACOLOGY
卷 738, 期 -, 页码 142-152

出版社

ELSEVIER
DOI: 10.1016/j.ejphar.2014.05.034

关键词

Shikonin; Autophagy; Reactive oxygen species; ERK; RIP; Hepatocellular carcinoma

资金

  1. National Natural Science Foundation of China [81273540]
  2. Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-13-0436]
  3. Distinguished Youth Foundation of Hubei Province of China [2012FFA019]
  4. Major Scientific and Technological Special Project for the Significant Creation of New Drugs [2011ZX09102-001-32]

向作者/读者索取更多资源

Shikonin, a naphthoquinone derived from the Chinese medicinal plant Lithospermum erythrornizon, shows potential to be a cancer chemotherapeutic agent. Our previous data demonstrate that high doses (about 6 mu M) of shikonin induce apoptosis in human hepatocellular carcinoma (HCC) cells. Here, we discovered that a low dose of shikonin (2.5 mu M) and a short treatment time (12 h) induced autophagy, as evidenced by the upregulation of microtubule-associated protein 1A/1B-light chain 3 (LC3)-II, the formation of acidic autophagic vacuoles (AVOs), and the punctate fluorescence pattern of GFP-LC3 protein. Next, we investigated the mechanism and found reactive oxygen species accumulation after shikonin treatment. The reactive oxygen species scavengers NAC and Tiron completely blocked autophagy. We further found activation of ERK by generation of reactive oxygen species and inhibition of RIP pathway, which are at least partially connected to shikonin-induced autophagy. Moreover, experiments in vivo revealed similar results: shikonin caused the accumulation of reactive oxygen species and phospho-ERK and thus induced autophagy in a tumor xenograft model. These findings suggest that shikonin is an inducer of autophagy and may be a promising clinical antitumor drug. (C) 2014 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据